Christopher Connelly

Title: Innovations by Christopher Connelly

Introduction

Christopher Connelly is an accomplished inventor based in Gretna, Nebraska. He has made significant contributions to the field of microbial resistance through his innovative patents. With a total of two patents to his name, Connelly's work focuses on the detection of antibiotic resistance, which is a critical issue in modern medicine.

Latest Patents

Connelly's latest patents include assays and methods for determining microbial resistance. These patents specifically address the detection of resistance to beta-lactam antibiotics. His work involves the identification of multiple β-lactamase family-specific gene targets using polymerase chain reaction or microarray techniques. The kits he developed include primers and/or probes for identifying various β-lactamase genes, such as MOX-like, FOX-like, ACC-like, and many others. Additionally, his kits may also target non-beta-lactamase gene families that confer antibiotic resistance, such as the MCR-1 gene.

Career Highlights

Throughout his career, Christopher Connelly has worked with notable organizations, including Streck, Inc. and Creighton University. His experience in these institutions has allowed him to further his research and contribute to advancements in microbial resistance detection.

Collaborations

Connelly has collaborated with several professionals in his field, including Maria Torres-Gonzalez and Nancy D. Hanson. These collaborations have enriched his research and expanded the impact of his inventions.

Conclusion

Christopher Connelly's innovative work in the field of microbial resistance detection highlights the importance of addressing antibiotic resistance in healthcare. His patents and collaborations reflect his commitment to advancing medical technology and improving patient outcomes.